Skip to main content

Volume 20 Supplement 1

Availability of quality-assured medical abortion medicines

Research

Publication of this supplement was funded by the UNDP–UNFPA–UNICEF–WHO–World Bank Special Programme of Research, Development and Research Training in Human Reproduction, a cosponsored programme executed by the WHO. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.

Edited by Friday Okonofua.


  1. Availability of quality-assured medical abortion medicines plays a crucial role in providing comprehensive abortion care. However, access to these medicines is still restricted for many abortion seekers. Incre...

    Authors: Ulrika Rehnström Loi, Ndola Prata, Amy Grossman, Antonella Lavelanet, Natalie Williams and Bela Ganatra
    Citation: Reproductive Health 2023 20(Suppl 1):20
    Content type: Methodology Published on:

  2. In recent years a growing number of manufacturers and medical abortion products have entered country markets and health systems, with varying degrees of quality and accessibility. An interplay of factors inclu...

    Authors: Amy Grossman, Ndola Prata, Natalie Williams, Bela Ganatra, Antonella Lavelanet, Laurence Läser, Chilanga Asmani, Hayfa Elamin, Leopold Ouedraogo, Md. Mahmudur Rahman, Musu Julie Conneh-Duworko, Bentoe Zoogley Tehoungue, Harriet Chanza, Henry Phiri, Bharat Bhattarai, Narayan Prasad Dhakal…
    Citation: Reproductive Health 2023 20(Suppl 1):58
    Content type: Research Published on:

    The Correction to this article has been published in Reproductive Health 2023 20:160

  3. In 2019, the World Health Organization identified improving access to safe abortion as an important priority toward improving sexual and reproductive health and rights and achieving Sustainable Development Goa...

    Authors: Meera Thapa Upadhyay, Terence Fusire, Ulrika Rehnström Loi, Annik Sorhaindo, Mohammed Salahuddin, Mohammed Ayub Hossain, Tashi Tshomo, Erna Mulati, Lovely Daisy, Dian Putri Anggraweni, Tumiur Gultom, Fitri Indrawati, Mariyam Jenyfa, Myint Myint Than, Bharat Bhattarai, Loshan Moonasinghe…
    Citation: Reproductive Health 2024 20(Suppl 1):191
    Content type: Research Published on:

  4. Despite their importance in reducing maternal mortality, information on access to Mifepristone, Misoprostol, and contraceptive medicines in the Eastern Mediterranean Region is limited.

    Authors: Mohamed Afifi, Nilmini Hemachandra, Qais Sikandar, Rana Hajjeh, Ulrika Rehnström Loi, Laurence Läser, Dima Qato, Zahir Sidiqui Abdul, Paata Chikvaidze, Raghad Abdul Redha Abbas, Khalid Al-Kinani, Hanan Hasan, Faysal El-Kak, Alissar Rady, Omelkheir Brngali, Mohamed Hashem…
    Citation: Reproductive Health 2024 20(Suppl 1):192
    Content type: Research Published on:

  5. Medical abortion with mifepristone and misoprostol can be provided up to 63 days’ gestation in India. This accounts for 67.5 percent of all abortions in the country. We conducted an assessment to determine the...

    Authors: Priya Karna, K. Aparna Sharma, Amy Grossman, Madhur Gupta, Tapas Chatterjee, Natalie Williams, Ndola Prata, Annik Sorhaindo, Laurence Läser, Ulrika Rehnström Loi, Bela Ganatra and Pushpa Chaudhary
    Citation: Reproductive Health 2024 20(Suppl 1):193
    Content type: Research Published on:

  6. The use of medical abortion using either a combination of mifepristone and misoprostol, or misoprostol alone has contributed to increased safety and decreased mortality and morbidity. The availability of quali...

    Authors: Amy Grossman, Ndola Prata, Sarah Jones, Laurence Läser, Bela Ganatra, Antonella Lavelanet, Natalie Williams, Chilanga Asmani, Hayfa Elamin, Leopold Ouedraogo, Lucy Sejo Maribe, Dina Vladimirovna Gbenou, Yelmali Clotaire Hien, Moussa Dadjoari, Fousséni Dao, Mariette Claudia Adame Gbanzi…
    Citation: Reproductive Health 2024 20(Suppl 1):195
    Content type: Research Published on:
Submit manuscript
BioMed Central logo, part of Springer Nature

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.6
    5-year Journal Impact Factor: 4.0
    Source Normalized Impact per Paper (SNIP): 1.496
    SCImago Journal Rank (SJR): 1.083

    Speed 2024
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 155

    Usage 2024
    Downloads: 2,812,663
    Altmetric mentions: 1,064

Read our Blogs

New Content Item

Journal Highlight: Reproductive Health and SDG3

We discuss how Reproductive Health is helping to address SDG3 and its targets.

New Content Item

Meet the SDG3 Researcher: Bright Ahinkorah

Meet Editor-in-Chief Bright Ahinkorah as he discusses his research and efforts to achieve the SDGs.

New Content Item

World Health Day 2025: Q&A with Hamdia Ahmed

Prof Hamdia Ahmed, REPH Associate Editor, discusses nursing and midwifery for World Health Day 2025.

New Content Item

World Health Day 2025: Q&A with Andrew Williams

Prof Andrew Williams, REPH Associate Editor, discusses reducing inequalities in maternal and child health for World Health Day 2025.

New Content Item

Engaging with African feminist interpretations of the Maternal

Read the blog by Ogochukwu Udenigwe on interpretations of motherhood and its relationship with patriarchal culture among African feminists.

New Content Item

Reaction to the 2024 Alabama Supreme Court ruling on IVF

Read the blog by Gwendolyn P. Quinn & Laura Kimberly on the Alabama Supreme Court ruling on IVF and what it means for women with cancer.

Reproductive Health

ISSN: 1742-4755